Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound - PubMed (original) (raw)
. 1995 Jan 15;55(2):259-66.
Affiliations
- PMID: 7812955
Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound
C V Rao et al. Cancer Res. 1995.
Abstract
Human epidemiological and laboratory animal model studies have suggested that nonsteroidal antiinflammatory drugs reduce the risk of development of colon cancer and that the inhibition of colon carcinogenesis is mediated through the alteration in cyclooxygenase metabolism of arachidonic acid. Curcumin, which is a naturally occurring compound, is present in turmeric, possesses both antiinflammatory and antioxidant properties, and has been tested for its chemopreventive properties in skin and forestomach carcinogenesis. The present study was designed to investigate the chemopreventive action of dietary curcumin on azoxymethane-induced colon carcinogenesis and also the modulating effect of this agent on the colonic mucosal and tumor phospholipase A2, phospholipase C gamma 1, lipoxygenase, and cyclooxygenase activities in male F344 rats. At 5 weeks of age, groups of animals were fed the control (modified AIN-76A) diet or a diet containing 2000 ppm of curcumin. At 7 weeks of age, all animals, except those in the vehicle (normal saline)-treated groups, were given two weekly s.c. injections of azoxymethane at a dose rate of 15 mg/kg body weight. All groups were continued on their respective dietary regimen until the termination of the experiment at 52 weeks after the carcinogen treatment. Colonic tumors were evaluated histopathologically. Colonic mucosa and tumors were analyzed for phospholipase A2, phospholipase C gamma 1, ex vivo prostaglandin (PG) E2, cyclooxygenase, and lipoxygenase activities. The results indicate that dietary administration of curcumin significantly inhibited incidence of colon adenocarcinomas (P < 0.004) and the multiplicity of invasive (P < 0.015), noninvasive (P < 0.01), and total (invasive plus noninvasive) adenocarcinomas (P < 0.001). Dietary curcumin also significantly suppressed the colon tumor volume by > 57% compared to the control diet. Animals fed the curcumin diet showed decreased activities of colonic mucosal and tumor phospholipase A2 (50%) and phospholipase C gamma 1 (40%) and levels of PGE2 (> 38%). The formation of prostaglandins such as PGE2, PGF2 alpha, PGD2, 6-keto PGF1 alpha, and thromboxane B2 through the cyclooxygenase system and production of 5(S)-, 8(S)-, 12(S)-, and 15(S)-hydroxyeicosatetraenoic acids via the lipoxygenase pathway from arachidonic acid were reduced in colonic mucosa and tumors of animals fed the curcumin diet as compared to control diet. Although the precise mechanism by which curcumin inhibits colon tumorigenesis remains to be elucidated, it is likely that the chemopreventive action, at least in part, may be related to the modulation of arachidonic acid metabolism.
Similar articles
- Chemoprevention of colon carcinogenesis by phenylethyl-3-methylcaffeate.
Rao CV, Desai D, Rivenson A, Simi B, Amin S, Reddy BS. Rao CV, et al. Cancer Res. 1995 Jun 1;55(11):2310-5. Cancer Res. 1995. PMID: 7757981 - Chemoprevention of colon carcinogenesis by sulindac, a nonsteroidal anti-inflammatory agent.
Rao CV, Rivenson A, Simi B, Zang E, Kelloff G, Steele V, Reddy BS. Rao CV, et al. Cancer Res. 1995 Apr 1;55(7):1464-72. Cancer Res. 1995. PMID: 7882354 - Enhancement of experimental colon carcinogenesis by dietary 6-phenylhexyl isothiocyanate.
Rao CV, Rivenson A, Simi B, Zang E, Hamid R, Kelloff GJ, Steele V, Reddy BS. Rao CV, et al. Cancer Res. 1995 Oct 1;55(19):4311-8. Cancer Res. 1995. PMID: 7671241 - Some perspectives on dietary inhibition of carcinogenesis: studies with curcumin and tea.
Conney AH, Lou YR, Xie JG, Osawa T, Newmark HL, Liu Y, Chang RL, Huang MT. Conney AH, et al. Proc Soc Exp Biol Med. 1997 Nov;216(2):234-45. doi: 10.3181/00379727-216-44173. Proc Soc Exp Biol Med. 1997. PMID: 9349692 Review. - [Arachidonic acid metabolism and vitamin E].
Parkhomets VP, Donchenko GV. Parkhomets VP, et al. Ukr Biokhim Zh (1978). 1992 Nov-Dec;64(6):3-11. Ukr Biokhim Zh (1978). 1992. PMID: 1488809 Review. Russian.
Cited by
- Phytochemicals as Immunomodulatory Molecules in Cancer Therapeutics.
Paudel S, Mishra N, Agarwal R. Paudel S, et al. Pharmaceuticals (Basel). 2023 Nov 26;16(12):1652. doi: 10.3390/ph16121652. Pharmaceuticals (Basel). 2023. PMID: 38139779 Free PMC article. Review. - Progastrin Peptides Increase the Risk of Developing Colonic Tumors: Impact on Colonic Stem Cells.
Singh P, Sarkar S, Kantara C, Maxwell C. Singh P, et al. Curr Colorectal Cancer Rep. 2012 Dec;8(4):277-289. doi: 10.1007/s11888-012-0144-3. Curr Colorectal Cancer Rep. 2012. PMID: 23226720 Free PMC article. - Phosphotyrosine profiling of curcumin-induced signaling.
Sathe G, Pinto SM, Syed N, Nanjappa V, Solanki HS, Renuse S, Chavan S, Khan AA, Patil AH, Nirujogi RS, Nair B, Mathur PP, Prasad TSK, Gowda H, Chatterjee A. Sathe G, et al. Clin Proteomics. 2016 Jun 15;13:13. doi: 10.1186/s12014-016-9114-0. eCollection 2016. Clin Proteomics. 2016. PMID: 27307780 Free PMC article. - Phytochemicals as Innovative Therapeutic Tools against Cancer Stem Cells.
Scarpa ES, Ninfali P. Scarpa ES, et al. Int J Mol Sci. 2015 Jul 10;16(7):15727-42. doi: 10.3390/ijms160715727. Int J Mol Sci. 2015. PMID: 26184171 Free PMC article. Review. - Curcumin synergizes with resveratrol to inhibit colon cancer.
Majumdar AP, Banerjee S, Nautiyal J, Patel BB, Patel V, Du J, Yu Y, Elliott AA, Levi E, Sarkar FH. Majumdar AP, et al. Nutr Cancer. 2009;61(4):544-53. doi: 10.1080/01635580902752262. Nutr Cancer. 2009. PMID: 19838927 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources